SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) financial statements, including revenue, expenses, profit, and loss
The total revenue of 0QN1 for the last semiannual is 14.11 M CHF, and it's 85.81% lower compared to the previous semiannual. The net income of H1 24 is -15.26 M CHF.